Weekly reads: custom CRISPR therapy for baby, stem cells make amniotic sacs, 2 anti-aging influencer tweets, Nurown
There has been a sizable downturn for the CRISPR therapy biotech arena. Firms like Editas, Verve, Intellia, and even CRISPR Therapeutics, which has garnered an FDA approval, have had struggles recently. It feels like a disconnect here in a way because overall gene editing and gene therapy have never seemed more promising. But being a […]